RTOG0617_2B: RTOG0617, figure 2B

RTOG0617_2BR Documentation

RTOG0617, figure 2B

Description

Kaplan-Meier digitized data from RTOG0617, figure 2B (PMID 25601342). A reported sample size of 166 for a primary endpoint of OS in lung cancer.

Usage

RTOG0617_2B

Format

A data frame of 465 observations and 3 variables:

time event time (in months)
event OS event indicator (0: no event, 1: event)
arm treatment arms (cetuximab, no_cetuximab)

Source

Bradley JD, Paulus R, Komaki R, et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol 2015; 16: 187–99.

Examples

summary(RTOG0617_2B)

kmplot(RTOG0617_2B)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.